THERMUS EXPRESSION SYSTEM

Information

  • Research Project
  • 2191180
  • ApplicationId
    2191180
  • Core Project Number
    R43GM052228
  • Full Project Number
    1R43GM052228-01A1
  • Serial Number
    52228
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/1995 - 29 years ago
  • Project End Date
    2/29/1996 - 28 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1995 - 29 years ago
  • Budget End Date
    2/29/1996 - 28 years ago
  • Fiscal Year
    1995
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    8/25/1995 - 29 years ago
Organizations

THERMUS EXPRESSION SYSTEM

ThermoGen proposes to develop a regulated expression system for the extreme thermophile Thermus flavus. This system will allow production of commercially important thermostable enzymes. In the Phase I feasibility study we will select promoter regions from Thermus, perform minimal structural analyses, and test their regulation using reporter genes in T. flavus. To fulfill this purpose, we will develop an integrative promoter-probe shuttle vector for Thermus based on a promoterless Thermo-beta-galactosidase and kanamycin phosphotransferase and a chromosomal integration system. Since commercially important proteins are often secretable, a search for signals suitable for regulated expression-secretion system will also be done. Phase II will focus on the development of the expression system into a functional tool for expressing both endogenous enzymes in Thermus, and for model experiments in protein thermostabilization. Further study on expression of hyperthermophilic proteins is also planed. In Phase III the expression system will be applied to the development of commercially important enzymes. PROPOSED COMMERCIAL APPLICATION: ThermoGen will develop an expression system for the extreme thermophile Thermus flavus. This expression system will allow the selective thermostabilization of mesophilic proteins with the emphasis of getting new products with therapeutic and industrial application.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    THERMOGEN, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CHICAGO
  • Organization State
    IL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    60612
  • Organization District
    UNITED STATES